miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling

Whether serine protease inhibitor Kazal type 1 (SPINK1) being associated with enzalutamide (Enz) resistance and metastasis of castration-resistant prostate cancer (CRPC) has not been clear. SPINK1 promoted Enz resistance by upregulating Androgen receptor splicing variant 7 (ARv7), and enhanced the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhi-Chao, Li, Yan, Wang, Ke-Liang, Wang, Lu, You, Bo-Sen, Zhao, Dan-Feng, Liu, Zhong-Qing, Fang, Rui-Zhe, Wang, Jia-Qi, Zhang, Wei, Zhang, Jin-Ming, Xu, Wan-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425449/
https://www.ncbi.nlm.nih.gov/pubmed/32694237
http://dx.doi.org/10.18632/aging.103485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425449/
https://www.ncbi.nlm.nih.gov/pubmed/32694237
http://dx.doi.org/10.18632/aging.103485

Ejemplares similares